Literature DB >> 11230704

Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma.

N Shivapurkar1, A Maitra, S Milchgrub, A F Gazdar.   

Abstract

Allelic losses at one or both arms of chromosome 4 are frequent in several tumor types, but information about colorectal carcinoma is limited. We have previously defined 4 nonoverlapping regions of frequent deletions in several tumor types. In an effort to more precisely locate the putative tumor suppressor gene(s) on chromosome 4 involved in the multistage pathogenesis of colorectal carcinomas, we performed loss of heterozygosity (LOH) studies using 19 polymorphic microsatellite markers. After precise microdissection of archival surgical cases, we determined LOH in DNA obtained from 23 colorectal adenocarcinomas, 20 colorectal adenomas, and from corresponding histologically normal-appearing colonic epithelial samples adjacent to the tumors and at the resection margins. We observed localized deletions of chromosome 4 at multiple regions in both carcinomas and adenomas. We identified deletions at 4 previously identified regions: R1 at 4q33-34 (18%-33%), R2 at 4q25-26 (45%-65%), R3 at 4p15.1-15.3 (35%-47%), and R4 at 4p16.3 (40%-49%). Six of fifteen (40%) cases examined with deletions of chromosome 4 in either adenocarcinomas or adenomas had loss of the same parental alleles in adjacent histologically normal epithelium but not in epithelial samples from the surgical resection margins. The deletions, which commenced on the short arm of chromosome 4 (regions R3 and/or R4), were more extensive in adenocarcinomas, intermediate in length in adenomas, and least extensive in histologically normal epithelium. Our results suggest that there may be multiple putative tumor suppressor genes located on both arms of chromosome 4 whose inactivation are important early events in the pathogenesis of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230704     DOI: 10.1053/hupa.2001.21560

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling.

Authors:  Lei Zhang; Ole Gjoerup; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

2.  Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.

Authors:  F Al-Mulla; S AlFadhli; A H Al-Hakim; J J Going; M S Bitar
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

Review 3.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

4.  Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas.

Authors:  Brandon Griess; David Klinkebiel; Alice Kueh; Michelle Desler; Kenneth Cowan; Matthew Fitzgerald; Melissa Teoh-Fitzgerald
Journal:  Epigenetics       Date:  2020-06-14       Impact factor: 4.528

5.  MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.

Authors:  Xinqi He; Yujuan Dong; Chung Wah Wu; Zengren Zhao; Simon S M Ng; Francis K L Chan; Joseph J Y Sung; Jun Yu
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

6.  Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.

Authors:  Hong Yu; Guangzhong Gao; Lin Jiang; Lingchuan Guo; Mei Lin; Xiao Jiao; Weiguang Jia; Junxing Huang
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

7.  Apoptotic threshold is lowered by p53 transactivation of caspase-6.

Authors:  Timothy K MacLachlan; Wafik S El-Deiry
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

8.  TACC3 is essential for EGF-mediated EMT in cervical cancer.

Authors:  Geun-Hyoung Ha; Jung-Lye Kim; Eun-Kyoung Breuer; Eun-Kyoung Yim Breuer
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

Review 9.  Function of Slit/Robo signaling in breast cancer.

Authors:  Feng Gu; Yongjie Ma; Jiao Zhang; Fengxia Qin; Li Fu
Journal:  Front Med       Date:  2015-11-05       Impact factor: 4.592

10.  Genomic profiling of prostate cancers from African American men.

Authors:  Patricia Castro; Chad J Creighton; Mustafa Ozen; Dror Berel; Martha P Mims; Michael Ittmann
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.